| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CANLET.2005.10.041 |
| P698 | PubMed publication ID | 16458421 |
| P50 | author | Güralp O Ceyhan | Q65581412 |
| Moritz N Wente | Q83717612 | ||
| Howard A Reber | Q117217097 | ||
| Oscar J Hines | Q117217098 | ||
| Markus Büchler | Q89169 | ||
| Helmut Friess | Q15453363 | ||
| P2093 | author name string | Marie D Burdick | |
| Robert M Strieter | |||
| Michael P Keane | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 221-227 | |
| P577 | publication date | 2006-02-03 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis | |
| P478 | volume | 241 |
| Q35498775 | A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2) |
| Q36464443 | Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis |
| Q34051950 | Angiogenesis and its targeting in rheumatoid arthritis |
| Q34051829 | Angiogenesis in rheumatoid arthritis. |
| Q27332024 | Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophages |
| Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
| Q40724369 | CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q37341761 | CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer |
| Q38020471 | CXCR2 in acute lung injury |
| Q36723785 | CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth |
| Q27021588 | CXCR2: a target for pancreatic cancer treatment? |
| Q101469934 | Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer |
| Q57492017 | Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity |
| Q33909030 | Chemokines and angiogenesis in rheumatoid arthritis. |
| Q36752040 | Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q30435873 | Chemokines as therapeutic targets in renal cell carcinoma |
| Q38786113 | Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK. |
| Q33602017 | Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness |
| Q38093364 | Contribution of bone marrow derived cells to the pancreatic tumor microenvironment |
| Q33346619 | ELR+ CXC chemokine expression in benign and malignant colorectal conditions |
| Q28743229 | Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer |
| Q33562569 | Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue |
| Q37332789 | Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin. |
| Q44608810 | High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma |
| Q34091347 | Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer |
| Q30608512 | K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways |
| Q41471434 | Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts |
| Q36984877 | Mechanisms of Disease: angiogenesis in inflammatory diseases |
| Q93061867 | Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5 |
| Q37534968 | Neutrophils: key mediators of tumour angiogenesis |
| Q34022062 | New insights in synovial angiogenesis. |
| Q30439835 | Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth |
| Q38797305 | Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. |
| Q30427989 | Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer |
| Q84405957 | Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma |
| Q41532653 | PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway |
| Q35498810 | Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes |
| Q55209569 | Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. |
| Q39069308 | Proteomic signatures of angiogenesis in androgen-independent prostate cancer |
| Q34004256 | Quantitative proteomic profiling studies of pancreatic cancer stem cells |
| Q35659991 | Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis |
| Q35770942 | Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. |
| Q36120825 | Role of chemokines in tumor growth |
| Q39321350 | Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases |
| Q33897910 | Roles of CXCL5 on migration and invasion of liver cancer cells |
| Q37227971 | Silencing of CXCR2 and CXCR7 protects against esophageal cancer |
| Q34537320 | Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedb |
| Q34058895 | Targeting Angiogenesis in Rheumatoid Arthritis |
| Q37062121 | Targeting angiogenesis in pancreatic cancer: rationale and pitfalls |
| Q36150219 | Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment |
| Q38982320 | The chemokine receptor-CXCR2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma in vitro and in vivo |
| Q38981288 | The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour. |
| Q34263645 | The emerging role of CXC chemokines and their receptors in cancer |
| Q33993124 | The role of chemoattractant receptors in shaping the tumor microenvironment. |
| Q37363612 | miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma |
Search more.